包茎治疗与男婴复发性尿路感染风险的系统综述
该系统综述检索PubMed、Embase、Cochrane Library、CINAHL、Scopus、Web of Science及ClinicalTrials.gov至2024年9月,评估包皮环切或局部糖皮质激素治疗包茎对男婴复发性尿路感染(rUTI)的预防效果。共3283篇摘要初筛、69篇全文评估,最终4篇符合纳入标准(2篇关于包皮环切,2篇关于局部糖皮质激素)。结果显示两种干预均可能降低rUTI风险,但证据有限,不足以进行荟萃分析。
要点
- 包皮环切后未见rUTI发生,未环切早产婴与男童rUTI比例分别为31%与11%。
- 局部糖皮质激素组27例均未发生rUTI,未治疗组165例中27例(16%)发生。
- 包皮可回缩者rUTI为7%,不可回缩者为30%,提示包皮回缩性是风险分层因素。
核心结论
- 本首个针对该主题的系统综述提示包皮环切与局部糖皮质激素可能降低男婴rUTI风险。
- 现有证据有限,不足以进行荟萃分析,需高质量研究明确其预防作用。
研究设计与样本
- 系统综述,按照PRISMA指南检索PubMed、Embase、Cochrane Library、CINAHL、Scopus、Web of Science及ClinicalTrials.gov至2024年9月。
- 初筛3283篇摘要,全文评估69篇,最终纳入4篇(2篇包皮环切、2篇局部糖皮质激素)。
- 仅纳入有既往UTI史的婴儿,两名作者独立评估,分歧由第三名作者解决,采用Joanna Briggs Institute工具评价质量与偏倚风险。
主要发现
- 约11/35(31%)未环切早产婴与6/53(11%)未环切男童发生rUTI,包皮环切后无一例发生。
- 27例接受局部糖皮质激素的未环切婴儿均未发生rUTI,而未治疗165例中27例(16%)发生。
- 一项研究中局部糖皮质激素组35/39(90%)包茎缓解,凡士林组8/39(21%)。
- 按包皮回缩性重新分类,可回缩者rUTI为2/28(7%),不可回缩者为8/27(30%)。
关键数值与推荐
- rUTI定义与纳入标准:仅纳入既往有UTI史的婴儿,排除无既往UTI者。
- 证据不足以合并,未报告汇总效应量或阈值。
临床怎么用
- 对反复UTI的男婴,可将包皮环切或局部糖皮质激素作为降低rUTI风险的选项考虑。
- 评估包皮回缩性有助于风险分层,不可回缩者rUTI比例更高。
局限性
- 仅4项研究符合纳入标准,证据有限,无法进行荟萃分析。
- 各研究间干预方式与人群定义存在异质性,结论需高质量研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effectiveness of phimosis treatment through circumcision or topical corticosteroids in preventing recurrent UTI (rUTI) in male infants. METHODS: A systematic review of PubMed, Embase, Cochrane Library, CINAHL, Scopus, Web of Science, and ClinicalTrials.gov was conducted through September 2024 per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. English-language articles with primary data on rUTI rates post-circumcision or topical corticosteroid treatment in infants were included. Articles were excluded if participants had not experienced a prior UTI. Two authors independently assessed abstracts and articles; a third resolved discrepancies. Joanna Briggs Institute Critical Appraisal Tools were applied for quality and risk of bias. RESULTS: Of 3283 abstracts, 69 full-text articles were reviewed, and 4 met inclusion criteria (2 on circumcision, 2 on topical corticosteroids). Around 11/35 (31%) uncircumcised premature infants and 6/53 (11%) uncircumcised boys developed a rUTI compared to none post-circumcision. Among 27 uncircumcised infants who received topical corticosteroids, none developed rUTI, versus 27/165 (16%) untreated infants. Another study found phimosis resolution in 35/39 (90%) infants using topical corticosteroids versus 8/39 (21%) using Vaseline. Infants were re-categorized by prepuce retractability, with rUTI in 2/28 (7%) infants with a retractile versus 8/27 (30%) with a non-retractile prepuce. CONCLUSION: This first systematic review on this topic suggests circumcision and topical corticosteroids may reduce rUTI risk, but available evidence is limited and insufficient for meta-analysis. High-quality studies are needed to clarify preventive role of these interventions in rUTI.
引用
- Heisinger-Heidler T, Shannon R, Meyer T, et al. Phimosis Treatment and Risk of Recurrent Urinary Tract Infection in Infant Males: A Systematic Review. Urology. 2025. PMID: 41274309. doi:10.1016/j.urology.2025.11.239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。